EMILIO
ESTEBAN GONZALEZ
Profesor Titular de Universidad
Monash University
Melbourne, AustraliaPublicaciones en colaboración con investigadores/as de Monash University (2)
2015
-
IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma
British Journal of Cancer, Vol. 112, Núm. 7, pp. 1190-1198
2014
-
Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: An open-label, randomised phase 3 trial
The Lancet Oncology, Vol. 15, Núm. 3, pp. 286-296